Trium Capital LLP Ngm Biopharmaceuticals Inc Transaction History
Trium Capital LLP
- $267 Million
- Q1 2024
A detailed history of Trium Capital LLP transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Trium Capital LLP holds 977,965 shares of NGM stock, worth $0. This represents 0.58% of its overall portfolio holdings.
Number of Shares
977,965Holding current value
$0% of portfolio
0.58%Shares
1 transactions
Others Institutions Holding NGM
# of Institutions
78Shares Held
36.9MCall Options Held
1.1KPut Options Held
200-
Column Group LLC San Francisco, CA18.1MShares$017.97% of portfolio
-
Black Rock Inc. New York, NY3MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$00.0% of portfolio
-
Step Stone Group LP La Jolla, CA1.57MShares$00.6% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.3MShares$023.2% of portfolio
About NGM BIOPHARMACEUTICALS INC
- Ticker NGM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,365,904
- Description
- NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...